(Q53642334)

16 May 2018

title

Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. (English)

1 reference

16 May 2018

1 reference

1 reference

Elliot K Fishman

1 reference

16 May 2018

author name string

Robert E Bristow

1 reference

16 May 2018

Marcela G del Carmen

1 reference

16 May 2018

Harpreet K Pannu

1 reference

16 May 2018

Christian Cohade

1 reference

16 May 2018

Mariana L Zahurak

1 reference

16 May 2018

Richard L Wahl

1 reference

16 May 2018

F J Montz

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 September 2003

1 reference

16 May 2018

published in

Gynecologic Oncology

1 reference

16 May 2018

volume

1 reference

16 May 2018

issue

1 reference

16 May 2018

page(s)

519-528

1 reference

16 May 2018

Second-line treatment of ovarian cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Playing the waiting game ... the asymptomatic patient with recurrent ovarian cancer detected only by rising Ca125 levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Long-term follow-up of ovarian cancer with monthly determinations of serum CA 125.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Computed tomography in evaluation of patients with ovarian carcinoma in complete clinical remission. Correlation with surgical-pathologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

CT prior to second-look operation in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Comparative evaluation of diagnostic methods in ovarian carcinoma with emphasis on CT and MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

CA 125 reliability in predicting ovarian cancer recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Secondary cytoreductive surgery for recurrent epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Recurrent ovarian carcinoma: is there a place for surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

PET scanning and measuring the impact of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Clinical Impact of 18F-FDG-PET in the Suspicion of Recurrent Ovarian Carcinoma Based on Elevated Tumor Marker Serum Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Image analysis in patients with cancer studied with a combined PET and CT scanner

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Combined PET/CT Imaging in Oncology. Impact on Patient Management

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

7. Survey of Results of Whole Body Imaging Using the PET/CT at the University of Pittsburgh Medical Center PET Facility

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Malignant tumors of the ovary managed with postoperative megavoltage irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

The role of 18F-fluoro-deoxyglucose positron emission tomography (18F-FDG PET) in diagnosis of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Experience with positron emission tomography (PET) scans in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

The use of PET scanning in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Ovarian carcinoma: value of CT in predicting success of debulking surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: An initial report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900336-6

7 January 2021

10.1016/S0090-8258(03)00336-6

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018